Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis - PDF (Russian)

Copyright (c) 2019 Kubanov A.A., Bakulev A.L., Samtsov A.V., Khairutdinov V.R., Sokolovskiy E.V., Kokhan M.M., Artemyeva A.V., Chernyaeva E.V., Ivanov R.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies